Dollar-cost averaging: what monthly buying did in the 2022 bear market

In 2022 the S&P 500 fell 25.4% from its peak. A $12,000 lump sum at the January peak ended the year at $9,606; $1,000 a month ended at $11,352 — and $14,103 by the end of 2023.

AI illustration for this news story: Dollar-cost averaging: what monthly buying did in the 2022 bear market
AI-generated illustration, not a photo.

The worst year in fourteen years

The S&P 500 opened 2022 at a record. On January 3, the index closed at 4,796.56, an all-time high. Twelve months later it closed the year at 3,839.50, down 19.4% on a price basis — its worst year since 2008. Between those two points it fell as far as 3,577.03 on October 12, a 25.4% drop from the peak.

The cause was no mystery. Inflation ran hot all year, and the Federal Reserve raised its key rate seven times, from a range of 0% to 0.25% to a range of 4.25% to 4.50%. Bonds fell alongside stocks, and the Nasdaq Composite lost 33.1% for the year. It was the first year since 2008 in which stocks and bonds both finished deep in the red — and a perfect laboratory for the oldest question in personal investing: when the market falls, is it better to invest everything at once, or a little at a time?

The test: $12,000 all at once, or $1,000 a month

Take an investor with $12,000 to put into an S&P 500 index fund at the start of 2022. The lump-sum buyer put it all in on January 3, at 4,796.56, buying 2.50 index units. By December 30, those units were worth $9,606 — a 20.0% loss. The monthly buyer put in $1,000 at the end of each month instead, buying more units when the index was low and fewer when it was high: 0.28 units in September, when the index closed at 3,585.62, against 0.22 units in March, when it closed at 4,530.41.

By year-end the monthly buyer held 2.96 units, bought at an average cost of $4,058.62, worth $11,352 — a 5.4% loss, and $1,746 ahead of the lump sum. The mechanism is the whole idea of dollar-cost averaging: investing the same amount at regular intervals, regardless of price. Investopedia describes the strategy as one that removes the uncertainty of market timing by sticking to a fixed schedule, and notes it is meant to help investors manage risk instead of increasing profitability.

Lump sum vs $1,000 a month: $12,000 in the S&P 500Source: Yahoo Finance
  • Lump sum, end of 2022$9,606, down 20.0%
  • Monthly buyer, end of 2022$11,352, down 5.4%
  • Monthly buyer's average cost$4,058.62
  • Lump sum, end of 2023$11,933, down 0.6%
  • Monthly buyer, end of 2023$14,103, up 17.5%
  • Monthly buyer ahead by end of 2023$2,170

The recovery year changed the scoreboard

The story did not end in December 2022. In 2023 the S&P 500 gained 24.2%, closing the year at 4,769.83, and it set a new closing high of 4,839.81 on January 19, 2024. The lump sum, left alone, recovered to $11,933 by the end of 2023 — still 0.6% below the original $12,000 after two years. The monthly buyer's 2.96 units were worth $14,103, up 17.5% on the money put in, and $2,170 ahead of the lump sum.

The falling year kept paying the monthly buyer long after it ended, because the extra units bought at low prices were still there when prices recovered. Morningstar's 2019 study of dollar-cost averaging found the same pattern in earlier downturns: averaging fares best in periods with negative total returns. In the technology correction from March 2000 through October 2002, monthly investing limited losses to 1.75%, against an annualized loss of 13.84% for the lump sum.

A dark stock market chart with a steep falling red line glowing on a screen at night
AI-generated illustration, not a photo.

What the test does and does not prove

None of this makes averaging the better choice in general. In a market that rises steadily, money held back to invest later misses part of the rise — the same reason Morningstar gives for why averaging usually trails investing at once. Vanguard's 2012 study found averaging came out ahead only about one third of the time, and Morningstar's own 2019 study found it improved returns in 27.8% of 10-month periods and 10.0% of 10-year periods. The 2022 test is a single episode, and a falling market is exactly where averaging is supposed to look good.

The test also hides the plan's real risk: the schedule only works if it is followed. An investor who stopped the monthly buys in October 2022, at the trough, would have missed the cheapest months and the recovery that followed. Investopedia's point is that the fixed schedule takes emotion out of investing — it only does its job when the investor lets it run. This is a simplified illustration, using price-only index levels at month-end closes, with no dividends and no fees, and it is not a forecast. Educational content, not investment advice.

Sources

Educational content, not investment advice. Facts as of the publish time above; figures come from the linked sources and markets change quickly. Genexus Alpha is not a registered investment adviser or broker.